ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionBellevue Group AG
Latest Disclosed Ownership159,346 shares
Latest Disclosed Value $ 35,769,990
Bellevue Group AG reports 1.16% decrease in ownership of RMD / ResMed Inc.

On May 14, 2026 - Bellevue Group AG filed a 13F-HR form disclosing ownership of 159,346 shares of ResMed Inc. (MX:RMD) valued at $35,769,990 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 161,214 shares of ResMed Inc.. This represents a change in shares of -1.16% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F RESMED COM 761152107 159,346 -1,868 -1.16 35,770 -7.89 0.8454
2026-02-17 2025-12-31 13F RESMED COM 761152107 161,214 -3,620 -2.20 38,832 -13.94 0.7359
2025-11-14 2025-09-30 13F RESMED COM 761152107 164,834 -968 -0.58 45,120 5.48 0.9375
2025-08-14 2025-06-30 13F RESMED COM 761152107 165,802 0 0.00 42,777 15.26 0.9428
2025-05-14 2025-03-31 13F RESMED COM 761152107 165,802 5,009 3.12 37,115 0.93 0.8316
2025-02-14 2024-12-31 13F RESMED COM 761152107 160,793 665 0.42 36,772 -5.93 0.7078
2024-11-14 2024-09-30 13F RESMED COM 761152107 160,128 4,247 2.72 39,090 31.01 0.6333
2024-08-14 2024-06-30 13F RESMED COM 761152107 155,881 125,490 412.92 29,839 395.81 0.4848
2024-05-15 2024-03-31 13F RESMED COM 761152107 30,391 71 0.23 6,018 15.40 0.0918
2024-02-14 2023-12-31 13F RESMED COM 761152107 30,320 -46,376 -60.47 5,216 -54.02 0.0798
2023-11-14 2023-09-30 13F RESMED COM 761152107 76,696 -21,579 -21.96 11,341 -47.18 0.1827
2023-08-14 2023-06-30 13F RESMED COM 761152107 98,275 0 0.00 21,473 -0.22 0.3063
2023-05-15 2023-03-31 13F RESMED COM 761152107 98,275 0 0.00 21,521 5.22 0.3123
2023-02-14 2022-12-31 13F RESMED COM 761152107 98,275 13,663 16.15 20,454 10.73 0.2715
2022-11-14 2022-09-30 13F RESMED COM 761152107 84,612 -253 -0.30 18,471 3.83 0.2651
2022-08-11 2022-06-30 13F RESMED COM 761152107 84,865 -1,484 -1.72 17,790 -15.04 0.2515
2022-05-13 2022-03-31 13F RESMED COM 761152107 86,349 -141 -0.16 20,940 -7.05 0.2432
2022-02-10 2021-12-31 13F RESMED COM 761152107 86,490 -1,655 -1.88 22,529 -3.02 0.2322
2021-11-12 2021-09-30 13F RESMED COM 761152107 88,145 0 0.00 23,231 6.91 0.2358
2021-08-12 2021-06-30 13F RESMED COM 761152107 88,145 0 0.00 21,730 27.06 0.2121
2021-05-12 2021-03-31 13F RESMED COM 761152107 88,145 -10,830 -10.94 17,102 -18.71 0.1809
2021-02-16 2020-12-31 13F RESMED COM 761152107 98,975 21,170 27.21 21,038 57.73 0.2409
2020-11-16 2020-09-30 13F RESMED COM 761152107 77,805 0 0.00 13,338 -10.72 0.1843
2020-08-13 2020-06-30 13F RESMED COM 761152107 77,805 -700 -0.89 14,939 29.20 0.2114
2020-05-14 2020-03-31 13F RESMED COM 761152107 78,505 2,695 3.55 11,563 -1.57 0.2242
2020-02-14 2019-12-31 13F RESMED COM 761152107 75,810 21,180 38.77 11,748 59.17 0.1863
2019-11-14 2019-09-30 13F RESMED COM 761152107 54,630 2,004 3.81 7,381 14.93 0.1373
2019-08-14 2019-06-30 13F RESMED COM 761152107 52,626 -2,041 -3.73 6,422 12.98 0.1097
2019-05-15 2019-03-31 13F RESMED COM 761152107 54,667 -725 -1.31 5,684 -9.88 0.3128
2019-02-12 2018-12-31 13F RESMED COM 761152107 55,392 -37,800 -40.56 6,307 -41.32 0.4147
2018-11-13 2018-09-30 13F RESMED COM 761152107 93,192 10,992 13.37 10,749 26.25 0.6819
2018-08-07 2018-06-30 13F RESMED COM 761152107 82,200 -24,800 -23.18 8,514 -19.19 0.7258
2018-05-09 2018-03-31 13F RESMED COM 761152107 107,000 60,000 127.66 10,536 164.72 1.0438
2018-02-14 2017-12-31 13F RESMED COM 761152107 47,000 0 0.00 3,980 10.04 0.4158
2017-11-13 2017-09-30 13F RESMED COM 761152107 47,000 10,900 30.19 3,617 28.67 0.3783
2017-08-14 2017-06-30 13F RESMED COM 761152107 36,100 28,100 351.25 2,811 388.02 0.3324
2017-05-11 2017-03-31 13F RESMED COM 761152107 8,000 0 0.00 576 16.13 0.0768
2017-02-10 2016-12-31 13F RESMED COM 761152107 8,000 0 0.00 496 -4.25 0.1016
2016-11-10 2016-09-30 13F ResMed COM 761152107 8,000 0 0.00 518 2.37 0.0936
2016-08-12 2016-06-30 13F ResMed COM 761152107 8,000 0 0.00 506 9.29 0.0952
2016-05-16 2016-03-31 13F ResMed COM 761152107 8,000 8,000 463 0.0840
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.